期刊文献+

一种用于检测麦考酚钠含量及有关物质的高效液相色谱法

High performance liquid chromatography for the determination of mycophenolate sodium and related substances
下载PDF
导出
摘要 目的:建立一种HPLC法用于麦考酚钠的含量及有关物质的测定。方法:采用MACHEREY-NA⁃GEL EC 250/3 NUCLEOSIL 100-5 C18(250 mm×3 mm,5μm)色谱柱,Welch Ghost-Buster(4.6 mm×50 mm)为鬼峰捕集小柱,以磷酸二氢钾缓冲盐(磷酸调pH至2.0)为流动相A,乙腈为流动相B,流速0.8 mL/min梯度洗脱,检测波长为216 nm,柱温为50℃。结果:麦考酚钠的检测限为0.008 g/mL,定量限为0.025 g/mL,麦考酚钠和杂质B在0.024~120 g/mL与峰面积线性关系良好,相关系数r均不小于0.999(n=5),麦考酚钠的回收率为100%,杂质B的回收率为102%。结论:该方法操作简单,重复性较好,适用于麦考酚钠含量及有关物质的测定。 Objective:To establish a HPLC method for the determination of mycophenolate sodium and related substances.Methods:MACHEREY-NAGELEC 250/3NUCLEOSIL 100-5C18(250mm×3mm,5μm)chromatographic column was used,Welch Ghost-Buster(4.6 mm×50 mm)was used as trap column,potassium dihydrogen phosphate buffer salt(adjusted to pH 2.0 by phosphoric acid)was used as mobile phase A,acetonitrile was used as mobile phase B,and elution was conducted with the flow rate of 0.8 mL/min gradient.The detection wavelength was 216 nm.Results:The detection limit of mycophenolate sodium was 0.008 g/mL,the quantitation limit was 0.025 g/mL,the linear relationship between mycophenolate sodium and impurity B was good at 0.024-120 g/mL,the correlation coefficient r was not less than 0.999(n=5),the recovery of mycophenolate sodium was 100%,and the recovery of impurity B was 102%.Conclusion:This method is simple,reproducible and suitable for the determination of mycophenolate sodium and related substances.
作者 张莹 张晓梅 徐建国 付静 Zhang Ying;Zhang Xiaomei;Xu Jiangguo;Fu Jing(College of Pharmacy,Jiangnan University,Wuxi 214122,China;Zhuohe Pharmaceutical Group Limited,Wuxi 214191,China)
出处 《江苏科技信息》 2021年第12期53-57,共5页 Jiangsu Science and Technology Information
关键词 麦考酚钠 含量 有关物质 高效液相色谱法 mycophenolate sodium content related substances high performance liquid chromatography
  • 相关文献

参考文献4

二级参考文献49

  • 1徐蓉,胡辉,朱健.新型免疫抑制抗生素霉酚酸酯的研究进展[J].温州大学学报,2005,18(6):58-60. 被引量:7
  • 2Iaccarino L, Rampudda M, Canova M, et al. Mycophenolate mofetil: What is its place in the treatment of autoimmune rheumatic diseases? [J]. Aatoimmtta Rev, 2007, 6(3) : 190-195.
  • 3Wu XY, Zha DQ, Xiang GS, et al. Combined MMF and insulin therapy prevents renal injury in experimental diabetic rats[J]. Cytokine, 2006, 36(5-6) : 229-236.
  • 4Suzuki C, Takahashi M, Morimoto H, et al. Mycophenolate mofetil attenuates pulmonary arterial hypertension in rats [ J ]. Biochem Biophys Res Commun, 2006, 349(2): 781-788.
  • 5Ying C, Colonno R, Clercq ED, et al. Ribavirin and mycophenolic acid markedly potentiate the anti-hepatitis B virus activity of entecavir[J]. Antiviral Res, 2007, 73(3) : 192-196.
  • 6Pourfarziani V, Panahi Y, Assari S, et al. Changing treatment protocol from azathioprine to mycophenolate mofetil: decrease in renal dysfunction, increase in infections [ J ]. Transplant Proc, 2007,39(4) : 1237-1240.
  • 7Fernandez A, Marcen R, Pascual J, et al. Mycophenolate mofetil levels in stable kidney transplant recipients [ J ]. Transplant Proc, 2007, 39(7): 2192-2184.
  • 8Gonzalez-Roncero FM, Govantes MAG, Chaves VC, et al. Influence of renal insufficiency on pharmacokinetics of ACYL-Glucuronide metabolite of mycophenoiic acid in renal transplant patients[J]. Transplant Proc. 2007, 39(7) : 2176-2178.
  • 9Pallardo LM, Oppenheimer F, Guirado, et al. Calcineurin inhibitor reduction based on maintenance immunosuppression with mycophenolate mofetil in renal transplant patients: POP Study [ J ]. Transplant Proc, 2007, 39(7) : 2187-2189.
  • 10Garcia R, Pinheiro-Machado PG, Felipe CR, et al. Conversion from azathioprine to mycophenolate mofetil followed by calcineurin inhibitor minimization or elimination in patients with chronic allograft dysfunction [ J ]. Transplant Proc, 2006, 38 ( 9 ) : 2872- 2878.

共引文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部